Posters and Publications
This page is intended to provide scientific information to research and healthcare professionals. Evofem Biosciences’ first commercial product was recently approved by the Food and Drug Administration. The Company is also advancing EVO100 into Phase 3 clinical trials for the prevention of urogenital transmission of both Chlamydia trachomatis infection (chlamydia) and Neisseria gonorrhoeae infection (gonorrhea) in women. EVO100 has not been approved by the Food and Drug Administration or any other regulatory agency.
Author(s) |
Publication |
Title |
Date |
|
Thomas, et al. |
Contraception X |
A Novel Vaginal pH Regulator: Results From The Phase 3 AMPOWER Contraception Clinical Trial |
July 2020 |
|
Chappell, et al. |
Annual Clinical and Scientific Meeting of the American College of Obstetricians and Gynecology (ACOG) |
Perfect-Use Pregnancy Rates with Vaginal pH Regulator: Efficacy Results from AMPOWER |
April 2020 |
|
Thomas, et al. |
Annual Clinical and Scientific Meeting of the American College of Obstetricians and Gynecology (ACOG) |
Sexual Satisfaction With Vaginal pH Regulator: Results From The AMPOWER Clinical Trial |
April 2020 |
|
Maximos, et al. |
Annual Clinical and Scientific Meeting of the American College of Obstetricians and Gynecology (ACOG) |
Genitourinary Side Effects With Vaginal pH Regulator: Results From AMPOWER |
April 2020 |
|
Cason, et al. |
Nurse Practitioners in Women’s Health (NPWH) Healthcare Conference |
Efficacy and Safety of a Vaginal pH Regulator: Results from the Phase 3, AMPOWER Clinical Trial |
Oct. 2019 |
|
Thomas, et al. |
American Society of Reproductive Medicine (ASRM) |
Women’s Satisfaction with the Vaginal pH Regulator (VPRTM): Results From the Phase 3 AMPOWER Trial |
Oct. 2019 |
|
Culwell K, et al. |
Fertility and Sterility |
Oct. 2017 |
|
|
Friend D |
2nd International Conference on Reproductive Health |
Amphora vaginal gel: An on-demand contraceptive with anti-STI (MPT) potential |
Dec. 2016 |
|
Thomas M, et al. |
Contraception Journal |
Oct. 2016 |
|
|
Barnhard K, et al. |
Obstetrics & Gynecology |
May 2016 |
|
|
Bayer L, et al. |
Contraception Journal |
July 2014 |
Evofem assumes no responsibility for the accuracy of any information or data contained on any third party website. Evofem has not independently verified the accuracy of such information or data, and there can be no assurance as to the accuracy of any such information or data. Links to this information and data are provided for informational purposes only.